Drugs becoming eligible for first Paragraph IV ANDA filing in 2030
Drugs expiring in 2031
Ultralente Insulin patents expiration
Mayne Pharma patents expiration
Drugs that contains Macimorelin Acetate
Topamax Sprinkle patents expiration
Bupivacaine Hydrochloride patents expiration
Drugs that contains Avibactam Sodium; Ceftazidime
